The subsequent adverse reactions are recognized during write-up-approval use of mycophenolic acid or other MPA derivatives.Reduction in immunosuppression needs to be thought of for sufferers who develop evidence of latest or reactivated viral bacterial infections. Physicians should also look at the possibility that minimized immunosuppression signi